Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Philipp Grosse-Gehling"'
Publikováno v:
Molecules, Vol 16, Iss 2, Pp 1129-1165 (2011)
The increasing application of positron emission tomography (PET) in nuclear medicine has stimulated the extensive development of a multitude of new radiotracers and novel radiolabeling procedures with the most prominent short-lived positron emitters
Externí odkaz:
https://doaj.org/article/d7e4e8bfa1b84a3ab3b0044a86ceae3d
Autor:
Claudia Dittfeld, Denis Corbeil, Malcolm R. Alison, Yvette Garbe, Philipp Grosse-Gehling, Leoni A. Kunz-Schughart, Christine A. Fargeas
Publikováno v:
The Journal of Pathology. 229:355-378
The cancer stem cell (CSC) hypothesis, despite the limitations of the currently available models and assays, has ushered in a new era of excitement in cancer research. The development of novel strategies for anti-tumour therapy relies on the use of b
Autor:
Leoni A. Kunz-Schughart, Oleg Chen, F. Manig, Sebastian R. Merker, Daniel E. Stange, Oleh V. Stasyk, Yaroslav Bobak, Philipp Grosse-Gehling, Thomas Henle, Yuliya Kurlishchuk, Steffen Löck, Bozhena Vynnytska-Myronovska
Publikováno v:
Oncotarget
// Yuliya Kurlishchuk 1, 2 , Bozhena Vynnytska-Myronovska 1, 2, 6 , Philipp Grosse-Gehling 1 , Yaroslav Bobak 2 , Friederike Manig 1, 3 , Oleg Chen 1, 2 , Sebastian R. Merker 4 , Thomas Henle 3 , Steffen Lock 1 , Daniel E. Stange 4 , Oleh Stasyk 2 ,
Autor:
Thomas Opfermann, Philipp Grosse-Gehling, M. Khalid, Thomas Kamradt, Hans-Peter Saluz, Jörg Steinbach, Lydia Würbach, Martin Walther, Stephan Preusche, Peter Gebhardt, Ingo M. Irmler
Publikováno v:
Applied Radiation and Isotopes. 69:852-857
We examined the production, separation, and characterization of (89)Zr, including supplementation of a commercial Cyclone(®) 18/9 with a self-made Solid Target System (STS). Obtained [(89)Zr]Zr-oxalate was used for the labeling of anti-B cell antibo
Publikováno v:
Radiochimica Acta. 99:365-373
The visualization of cyclin-dependent kinases (CDKs), which are overexpressed in multiple tumor types, with radiolabeled CDK inhibitors by means of positron emission tomography in vivo is a promising approach for tumor imaging. Pyrido[2,3-d]pyrimidin
Autor:
Philipp, Grosse-Gehling, Christine A, Fargeas, Claudia, Dittfeld, Yvette, Garbe, Malcolm R, Alison, Denis, Corbeil, Leoni A, Kunz-Schughart
Publikováno v:
The Journal of pathology. 229(3)
The cancer stem cell (CSC) hypothesis, despite the limitations of the currently available models and assays, has ushered in a new era of excitement in cancer research. The development of novel strategies for anti-tumour therapy relies on the use of b
Publikováno v:
Seminars in radiation oncology. 22(2)
Cancer stem cell research is one of the most thriving and competitive areas in oncology research because it has the potential to dramatically affect clinical outcomes. Led by progress in hematology, cancer stem cell research has now provided evidence
Publikováno v:
ChemInform. 42
Autor:
Philipp Grosse-Gehling, Thomas Kamradt, Hans-Peter Saluz, Stephan Preusche, Jörg Steinbach, Peter Gebhardt, Ingo M. Irmler, Thomas Opfermann, Martin Walther, Lydia Würbach
Publikováno v:
Nuclear Medicine and Biology. 37:697